The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)


Unfractionated heparin versus bivalirudin in patients undergoing primary percutaneous coronary intervention: a SWEDEHEART study

EuroIntervention 2017;12:2009-2017 published online January 2017. DOI: 10.4244/EIJ-D-16-00884

1. Department of Medical Sciences, Cardiology, Uppsala University, Uppsala, Sweden; 2. Department of Cardiology, Västerås Hospital, Västerås, Sweden; 3. Department of Cardiology, Skåne University Hospital, Lund University, Lund, Sweden; 4. Uppsala Clinica

Aims: The aim of the study was to compare outcomes in unfractionated heparin (UFH) and bivalirudin-treated patients undergoing primary percutaneous coronary intervention (PPCI).

Sign in to read and download the full article

Forgot your password?
No account yet? Sign up for free!
Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from

Read next article
Clinical events beyond one year after an acute coronary syndrome: insights from the RECLOSE 2-ACS study